New study data demonstrates Lodestar more accurate than lab culture

In an independent study undertaken at the Royal Berkshire Hospital, in September to October 2025, Lodestar was tested against the standard method for testing UTIs – MC&S (Microscopy, Culture & Sensitivity) or lab culture.

The exercise was designed to compare how accurate Lodestar DX is against the ‘gold standard’ method of MC&S and also the less reliable but often used dipstick testing method.

The results were clear. Based on results from 75 samples “Lodestar demonstrated an accuracy rate (negative predictive value) of 86%, outperforming both MC&S a(58.8%) and dipstick (45%).”

In other words, Lodestar is approximately 33% more accurate than the current ‘gold standard’ testing method. And, in the words of Mr Bob Yang, consultant urologist at the Royal Berkshire, it proves that dipstick “is less accurate than tossing a coin.”